R01 CA102613/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2006	1
2007	1
2008	2
2009	4
2010	2
2011	5
2012	8
2013	7
2014	9
2015	4
2016	3
2017	9
2018	4
2019	3
2020	2
2021	3
2022	2
2023	2
2024	1

1

Nomograms in oncology: more than meets the eye.

Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Balachandran VP, et al. Lancet Oncol. 2015 Apr;16(4):e173-80. doi: 10.1016/S1470-2045(14)71116-7. Lancet Oncol. 2015. PMID: 25846097 Free PMC article. Review.

2

Tailored management of primary gastrointestinal stromal tumors.

Etherington MS, DeMatteo RP. Etherington MS, et al. Cancer. 2019 Jul 1;125(13):2164-2171. doi: 10.1002/cncr.32067. Epub 2019 Apr 1. Cancer. 2019. PMID: 30933313 Free PMC article. Review.

3

Principles of Kinase Inhibitor Therapy for Solid Tumors.

Cohen NA, Kim TS, DeMatteo RP. Cohen NA, et al. Ann Surg. 2017 Feb;265(2):311-319. doi: 10.1097/SLA.0000000000001740. Ann Surg. 2017. PMID: 27058947 Free PMC article. Review.

4

Tyrosine Kinase Inhibition Activates Intratumoral γδ T Cells in Gastrointestinal Stromal Tumor.

Etherington MS, Hanna AN, Medina BD, Liu M, Tieniber AD, Kwak HV, Tardy KJ, Levin L, Do KJ, Rossi F, Zeng S, DeMatteo RP. Etherington MS, et al. Cancer Immunol Res. 2024 Jan 3;12(1):107-119. doi: 10.1158/2326-6066.CIR-23-0061. Cancer Immunol Res. 2024. PMID: 37922405

5

Metastasectomy for gastrointestinal stromal tumors.

Bamboat ZM, DeMatteo RP. Bamboat ZM, et al. J Surg Oncol. 2014 Jan;109(1):23-7. doi: 10.1002/jso.23451. Epub 2013 Oct 24. J Surg Oncol. 2014. PMID: 24155153 Free PMC article. Review.

6

Myosin Light-Chain Kinase Inhibition Potentiates the Antitumor Effects of Avapritinib in PDGFRA D842V-Mutant Gastrointestinal Stromal Tumor.

Rossi F, Liu M, Tieniber A, Etherington MS, Hanna A, Vitiello GA, Param NJ, Do K, Wang L, Antonescu CR, Zeng S, Zhang JQ, DeMatteo RP. Rossi F, et al. Clin Cancer Res. 2023 Jun 1;29(11):2144-2157. doi: 10.1158/1078-0432.CCR-22-0533. Clin Cancer Res. 2023. PMID: 36971786 Free PMC article.

7

Gastrointestinal stromal tumors: who should get imatinib and for how long?

Balachandran VP, DeMatteo RP. Balachandran VP, et al. Adv Surg. 2014;48(1):165-83. doi: 10.1016/j.yasu.2014.05.014. Adv Surg. 2014. PMID: 25293614 Free PMC article. Review.

8

The GIST of targeted therapy for malignant melanoma.

Bello DM, Dematteo RP, Ariyan CE. Bello DM, et al. Ann Surg Oncol. 2014 Jun;21(6):2059-67. doi: 10.1245/s10434-013-3373-z. Epub 2014 Feb 15. Ann Surg Oncol. 2014. PMID: 24531699 Free PMC article. Review.

9

Adjuvant imatinib for GIST: the pie is shrinking.

Balachandran VP, DeMatteo RP. Balachandran VP, et al. Ann Surg Oncol. 2014 Oct;21(11):3365-6. doi: 10.1245/s10434-014-3992-z. Epub 2014 Aug 14. Ann Surg Oncol. 2014. PMID: 25120253 Free PMC article. No abstract available.

10

NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.

Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, Pisters PW, Raut CP, Riedel RF, Schuetze S, Sundar HM, Trent JC, Wayne JD. Demetri GD, et al. J Natl Compr Canc Netw. 2010 Apr;8 Suppl 2(0 2):S1-41; quiz S42-4. doi: 10.6004/jnccn.2010.0116. J Natl Compr Canc Netw. 2010. PMID: 20457867 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

63 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year